Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1828]
News [2773]
Articles [208]
Editorials [1]
Conferences [136]
elearning [13]
EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia and coexisting comorbidities
EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously...
Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival
Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival
A homing beacon for chemotherapy drugs
A homing beacon for chemotherapy drugs
A 'one-two punch' to wipe out cancerous ovarian cells
A 'one-two punch' to wipe out cancerous ovarian cells
FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma
FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma
FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphoma
FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphoma
Long exposure to protein inhibitor may be key to more effective chemotherapy for cancer
Long exposure to protein inhibitor may be key to more effective chemotherapy for cancer
A molecular glue to overcome cancer drug resistance?
A molecular glue to overcome cancer drug resistance?
Radio-wave therapy proves effective against liver cancer cells
Radio-wave therapy proves effective against liver cancer cells
ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery
ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation